Patients at risk as NHS and online prescriptions not joined up
Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
Interventions: Other: No Intervention: Observational Cohort
Sponsors: Second Affiliated Hospital of Nanchang University
Recruiting
AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images
Sponsors: Istanbul Training and Research Hospital
Recruiting
Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) – Frozen Embryo Transfer (FET) Cycles
Interventions: Other: Endometrial peristalsis and hormone measurements
Sponsors: Mỹ Đức Hospital
Not yet recruiting
The effect of weather on unscheduled healthcare utilisation for mental health conditions in England, 2014–2022
Final speakers announced for Summer Schools 2026
Opinion: Banning gender-affirming care doesn’t protect children — it makes it harder to help them
I am a plastic surgeon who rebuilds faces after car accidents, helps cancer patients breathe, and restores infants’ ability to eat and smile. Yet what draws the most notice is my work transforming masculine features into feminine ones, and vice versa.
I am an outsider to the LGBTQIA+ community. I grew up in a conservative household in which discussions on sex and gender were taboo. But in residency, I saw patients in clinic every Monday with my attending, a cisgender, white, heterosexual male at least 60 years old, who had been providing surgical gender-affirming care for over 25 years. I saw how vulnerable the patients were, trapped in their bodies. I felt the weight they woke up with every day, trying to blend into the surrounding world of instantaneous judgements. And I saw the life-changing impact that surgery had.
AI underused where it could deliver productivity gains, says RCR
Improving Models to Predict Care Utilization Using Machine Learning: Retrospective Observational Study
Background: The use of artificial intelligence and machine learning (ML) tools is now common in the advancement of health care services and clinical risk estimation. Legacy systems make use of highly informative feature sets developed from years of clinical expertise and research to estimate different outcomes, but only recently have they been tested against novel statistical approaches. One such system, the Johns Hopkins Adjusted Clinical Group (ACG) System, is a long-standing and widely used approach to categorizing clinical risk factors, and it is amenable to ML techniques. Objective: This study aims to test the ACG System using a contrasted area under the receiver operating characteristic (AUROC) and classification optimization strategy and compare its performance against traditional logistic regression methods. Assuming that selected ML algorithms can be tuned to enhance overall measures of performance, this would strengthen arguments for incorporating them into ACG-related workflows. Methods: Using a retrospective observational design, prospective year estimates of all-cause hospitalization and elevated total cost were modeled using a cross-validation framework. Patients with elevated costs were identified as those falling above the 95th percentile of total amounts billed, including pharmacy costs. Hyperparameter settings for XGBoost (Extreme Gradient Boosting), random forest, and elastic net were determined using average cross-validated performances for and AUROC in a grid search aimed at maximizing either statistic. Additional iterated cross-validation was used to compare point-estimated average AUROC and -scores between models, further decomposed by sensitivity, positive predictive value, and -beta statistics. Results: There were 350,463 patients selected in 2019 from the Johns Hopkins Health System. Model features identified by the ACG System for predicting prospective year hospitalization and total cost were included in these analyses. Findings suggest small but statistically significant improvements in cross-validated AUROC and -scores over logistic regression, using either optimization strategy and XGBoost. Logistic models achieved average receiver operating characteristic values of 0.886 and 0.841 for cost and hospitalization, respectively, whereas XGBoost achieved 0.891 and 0.849, respectively. optimization yielded similar findings, with logistic models achieving 0.367 and 0.341 on average for hospitalization and cost, respectively, but XGBoost exceeded values for cost but not for hospitalization (0.411 and 0.328, respectively). Conclusions: The clinical implications of these findings and the effect of class imbalance on model calibration are explored, along with the limitations of these data and approach. The core finding is that logistic regression remains very well-suited to these tasks, especially in situations where the efficiency or interpretability of models is critical. Under conditions of imbalance, regressions tended to yield high-precision estimates for the outnumbered class. Nevertheless, the findings also underscore a diversity of suitable models depending on clinical use cases, each having its own tradeoffs for evaluating performance. As such, health systems must clearly identify the needs and expectations of a model before calibrating one for use.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/cc6a31773ec690198d6914d248fe33eb" />

